Table 2 Prevalence of any hepatic metastasis in cohorts stratified by NFS, FIB4 and ARPI
Group (%) | Hepatic metastasis free | Hepatic metastasis | P value |
|---|---|---|---|
NFS | |||
 Low | 1480 (91.3) | 141 (8.7) | 0.017 |
 High | 24 (77.4) | 7 (22.6) | |
NFS modified | |||
 Low | 1009 (92.6) | 81 (7.4) | 0.003 |
 High | 495 (88.1) | 67 (11.9) | |
FIB4 | |||
 Low | 1112 (91.9) | 98 (8.1) | 0.001 |
 Intermediate | 371 (89.8) | 42 (10.2) | |
 High | 21 (72.4) | 8 (27.6) | |
FIB4 modified | 0.018 | ||
 Low | 1112 (91.9) | 98 (8.1) | |
 Intermediate | 336 (89.8) | 38 (10.2) | |
 High | 56 (82.4) | 12 (17.6) | |
APRI | 0.049 | ||
 Low | 1428 (91.4) | 135 (8.6) | |
 High | 76 (85.4) | 13 (14.6) | |